Cargando…

Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease

Background: Sphingolipids mainly consist of ceramides (Cer), sphingomyelins (SM) and glycosphingolipids. Sphingolipids are related with coronary heart disease and metabolic disease, but there’re few studies about cerebrovascular disease. The purpose was to detect sphingolipids in plasma of patients...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Qian, Peng, Qing, Yu, Zemou, Jin, Haiqiang, Zhang, Jing, Sun, Wei, Huang, Yining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502657/
https://www.ncbi.nlm.nih.gov/pubmed/32830858
http://dx.doi.org/10.1042/BSR20201519
_version_ 1783584245855289344
author You, Qian
Peng, Qing
Yu, Zemou
Jin, Haiqiang
Zhang, Jing
Sun, Wei
Huang, Yining
author_facet You, Qian
Peng, Qing
Yu, Zemou
Jin, Haiqiang
Zhang, Jing
Sun, Wei
Huang, Yining
author_sort You, Qian
collection PubMed
description Background: Sphingolipids mainly consist of ceramides (Cer), sphingomyelins (SM) and glycosphingolipids. Sphingolipids are related with coronary heart disease and metabolic disease, but there’re few studies about cerebrovascular disease. The purpose was to detect sphingolipids in plasma of patients with large artery atherosclerosis (LAA) cerebrovascular disease and cerebral small vessel disease (CSVD) to explore the similarities and differences of pathogenesis of the two subtypes. Methods: 20 patients with LAA cerebrovascular disease, 20 patients with age-related CSVD, 10 patients with Fabry disease and 14 controls were enrolled from October 2017 to January 2019. Ultra-high performance liquid chromatography-quadruple-time-of-flight mass spectrometry/mass spectrometry was used to determine sphingolipids. Univariate combined with multivariate analysis was used for comparison. Receiver operating characteristic curves were used to determine sensitivities and specificities. Results: 276 sphingolipids were detected, including 39 Cer, 3 ceramide phosphates, 72 glycosphingolipids and 162 SM. (1) Cer (d36:3), Cer (d34:2), Cer (d38:6), Cer (d36:4) and Cer (d16:0/18:1) were increased in LAA; SM (d34:1), Cer (d34:2), Cer (d36:4), Cer (d16:0/18:1), Cer (d38:6), Cer (d36:3) and Cer (d32:0) were increased in age-related CSVD. (2) Cer (d36:4) and SM (d34:1) were increased in age-related CSVD compared with LAA. (3) Total trihexosyl ceramides were increased in Fabry group compared with control (P<0.05); SM (d34:1) was increased in Fabry group. Conclusions: Ceramides are increased in both LAA and age-related CSVD, which may be related to similar risk factors and pathophysiological process of arteriosclerosis; SM is increased in both age-related CSVD and Fabry disease, suggesting that increased SM may be associated with CSVD. Glycosphingolipids, trihexosylceramides in particular, are increased in Fabry disease.
format Online
Article
Text
id pubmed-7502657
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75026572020-09-28 Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease You, Qian Peng, Qing Yu, Zemou Jin, Haiqiang Zhang, Jing Sun, Wei Huang, Yining Biosci Rep Diagnostics & Biomarkers Background: Sphingolipids mainly consist of ceramides (Cer), sphingomyelins (SM) and glycosphingolipids. Sphingolipids are related with coronary heart disease and metabolic disease, but there’re few studies about cerebrovascular disease. The purpose was to detect sphingolipids in plasma of patients with large artery atherosclerosis (LAA) cerebrovascular disease and cerebral small vessel disease (CSVD) to explore the similarities and differences of pathogenesis of the two subtypes. Methods: 20 patients with LAA cerebrovascular disease, 20 patients with age-related CSVD, 10 patients with Fabry disease and 14 controls were enrolled from October 2017 to January 2019. Ultra-high performance liquid chromatography-quadruple-time-of-flight mass spectrometry/mass spectrometry was used to determine sphingolipids. Univariate combined with multivariate analysis was used for comparison. Receiver operating characteristic curves were used to determine sensitivities and specificities. Results: 276 sphingolipids were detected, including 39 Cer, 3 ceramide phosphates, 72 glycosphingolipids and 162 SM. (1) Cer (d36:3), Cer (d34:2), Cer (d38:6), Cer (d36:4) and Cer (d16:0/18:1) were increased in LAA; SM (d34:1), Cer (d34:2), Cer (d36:4), Cer (d16:0/18:1), Cer (d38:6), Cer (d36:3) and Cer (d32:0) were increased in age-related CSVD. (2) Cer (d36:4) and SM (d34:1) were increased in age-related CSVD compared with LAA. (3) Total trihexosyl ceramides were increased in Fabry group compared with control (P<0.05); SM (d34:1) was increased in Fabry group. Conclusions: Ceramides are increased in both LAA and age-related CSVD, which may be related to similar risk factors and pathophysiological process of arteriosclerosis; SM is increased in both age-related CSVD and Fabry disease, suggesting that increased SM may be associated with CSVD. Glycosphingolipids, trihexosylceramides in particular, are increased in Fabry disease. Portland Press Ltd. 2020-09-18 /pmc/articles/PMC7502657/ /pubmed/32830858 http://dx.doi.org/10.1042/BSR20201519 Text en © 2020 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
spellingShingle Diagnostics & Biomarkers
You, Qian
Peng, Qing
Yu, Zemou
Jin, Haiqiang
Zhang, Jing
Sun, Wei
Huang, Yining
Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
title Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
title_full Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
title_fullStr Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
title_full_unstemmed Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
title_short Plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
title_sort plasma lipidomic analysis of sphingolipids in patients with large artery atherosclerosis cerebrovascular disease and cerebral small vessel disease
topic Diagnostics & Biomarkers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7502657/
https://www.ncbi.nlm.nih.gov/pubmed/32830858
http://dx.doi.org/10.1042/BSR20201519
work_keys_str_mv AT youqian plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease
AT pengqing plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease
AT yuzemou plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease
AT jinhaiqiang plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease
AT zhangjing plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease
AT sunwei plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease
AT huangyining plasmalipidomicanalysisofsphingolipidsinpatientswithlargearteryatherosclerosiscerebrovasculardiseaseandcerebralsmallvesseldisease